New Publication Alert | World Cell Biologist Awards
HIF1α: A Novel Biomarker with Potential Prognostic and Immunotherapy in Pan-cancer
A compelling study highlights HIF1α as a potential pan-cancer biomarker, exploring its relationship with tumor progression, prognosis, immune infiltration, and therapeutic opportunities.
Key Highlights:
• Investigated HIF1α across 33 cancer types
• Explored gene expression, mutations, and immune associations
• Identified links with prognosis and tumor immunity
• Highlighted potential applications in diagnosis and treatment research
Published in: Oxidative Medicine and Cellular Longevity
Year: 2022
DOI: 10.1155/2022/1246267
A promising biomarker for better cancer care.
World Cell Biologist Awards
Honoring Research. Inspiring the Future.
Visit Now: cellbiologist.org
Nominate Now: https://c-i.li/RegisterWCBContact Us: help@cellbiologist.org
#worldresearchawards #researchawards #
Comments
Post a Comment